Latest filing published 02 Nov 2009 for Patriot National Bancorp INC, €137.
No signal scores available.
Based on 47 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Angelo Decaro discloses dealings in 2 companies, chiefly Patriot National Bancorp Inc and Innovive Pharmaceuticals, Inc. In total, 95 filings cover trades dated from 29 September 2006 to 30 October 2009.
Both buying and selling appear: 48 purchases worth €373k, against 46 sales worth €390k. The net balance comes to €18k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2009, the count stands at no purchases and 46 sales.
Half of the purchases are above €2,480 and half below. For 47 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 2% of cases, with a median move of -9.7%. These figures describe past trades and do not predict future prices.
On 2 November 2009 came the latest disclosure, an open-market sale for €679 in Patriot National Bancorp Inc. The most recent open-market purchase was published on 25 November 2008, 6,542 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 94 declarations